Relationship between fibroblast growth factor 21 and thyroid stimulating hormone in healthy subjects without components of metabolic syndrome

Publisher： Compuscript

ISSN： 2305-6983

Source： Family Medicine and Community Health, Vol.2, Iss.3, 2014-01, pp. : 1-6

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Fibroblast Growth Factor-21 as a Therapeutic Agent for Metabolic Diseases

By Kharitonenkov Alexei Shanafelt Armen B.

BioDrugs, Vol. 22, Iss. 1, 2008-01 ,pp. : 37-44

Adis International

Access to resources Recommend Favorite

Recombinant Human Thyroid-Stimulating Hormone: Pharmacology, Clinical Applications and Potential Uses

By Emerson C.H. Torres M.S.T.

BioDrugs, Vol. 17, Iss. 1, 2003-01 ,pp. : 19-38

Adis International

Access to resources Recommend Favorite

The Relationship of Metabolic Syndrome and Health-Promoting Lifestyle Profiles of Latinos in the Northwest

By Sutherland Leonie L. Simonson Shawn Weiler Dawn M. Reis Janet Channel Amara

Hispanic Health Care International, Vol. 12, Iss. 3, 2014-09 ,pp. : 130-137

Springer Publishing Company

Access to resources Recommend Favorite

Potential of Recombinant Human Growth Hormone in HIV-Associated Adipose Redistribution Syndrome

By Torres R.A.

BioDrugs, Vol. 14, Iss. 2, 2000-08 ,pp. : 83-91

Adis International

Access to resources Recommend Favorite

Therapeutic Angiogenesis: Potential Role of Basic Fibroblast Growth Factor in Patients with Severe Ischaemic Heart Disease

By Simons M. Laham R.J. Post M. Sellke F.W.

BioDrugs, Vol. 14, Iss. 1, 2000-07 ,pp. : 13-20

Adis International

Access to resources Recommend Favorite